View in EDS HTML Full Text PDF Full Text

Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study.

Saved in:
Bibliographic Details
Title: Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study.
Authors: Pasello G; Department of Surgery Oncology and Gastroenterology, University of Padova, Padua, Italy.; Oncology 2, Istituto Oncologico Veneto IRCCS, Padua, Italy., Proto C; Istituto Nazionale Tumori, Milan, Italy., Genova C; Ospedale Policlinico San Martino, Genoa, Italy., Pavan A; Department of Medical Oncology, AULSS 3 Serenissima, Ospedale dell'Angelo, Venezia, Italy., Roca E; Thoracic Oncology - Lung Unit, Pederzoli Hospital, Peschiera del Garda, Verona, Italy., Minuti G; Clinical Trials Unit - Phase 1 and Precision Medicine, IRCCS National Cancer Institute Regina Elena, Rome, Italy., D'Aniello C; Unit of Oncology, A.O. dei Colli P.O. Monaldi, Naples, Italy., Giusti R; A.O.U. Sant'Andrea, Rome, Italy., Mariotti S; Policlinico Tor Vergata, Rome, Italy., Romano FJ; A.O.R.N. Cardarelli, Naples, Italy., Polo V; Oncology Unit, AULSS 2 Marca Trevigiana, Ca' Foncello Hospital, Treviso, Italy., Belluomini L; Section of Oncology, Department of Engineering for Innovation Medicine (DIMI), University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Baldini E; Ospedale San Luca, Lucca, Italy., Mazzoni F; Oncology Department, Careggi University Hospital, Florence, Italy., Bettini AC; ASST Papa Giovanni XXIII, Bergamo, Italy., Gristina V; Department of Precision Medicine in Medical, Surgical and Critical Care, AOUP Paolo Giaccone University Hospital, Palermo, Italy., Russo A; A.O. Papardo, Messina, Italy., Grossi F; Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy.; Medical Oncology Division, ASST Sette Laghi, Varese, Italy., Ogliari FR; Dept. Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.; Università Vita-Salute San Raffaele, Pesaro (PU), Milan, Italy., Gelsomino F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Chiari R; Ospedale San Salvatore - Muraglia, Pesaro (PU), Italy., Bria E; Fondazione Policlinico Universitario A. Gemelli, Rome, Italy., Fioroni I; Policlinico Universitario Campus Bio-Medico, Rome, Italy., Cortinovis D; SC Medical Oncology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; Department of Medicine, University of Milano-Bicocca, Milan, Italy., Pizzutilo EG; ASST GOM Niguarda, Milan, Italy., Zanetti A; AstraZeneca Italy, Milan, Italy., Pasqualetti G; AstraZeneca Italy, Milan, Italy., Roncari B; IQVIA Solutions Italy SRL, Modena, Italy., Simoni L; IQVIA Solutions Italy SRL, Modena, Italy., Catino A; Thoracic Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Corporate Authors: ELBA Study Group
Source: Frontiers in oncology [Front Oncol] 2026 Feb 16; Vol. 16, pp. 1724019. Date of Electronic Publication: 2026 Feb 16 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41777656
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pasello+G%22">Pasello G</searchLink>; Department of Surgery Oncology and Gastroenterology, University of Padova, Padua, Italy.; Oncology 2, Istituto Oncologico Veneto IRCCS, Padua, Italy.<br /><searchLink fieldCode="AU" term="%22Proto+C%22">Proto C</searchLink>; Istituto Nazionale Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Genova+C%22">Genova C</searchLink>; Ospedale Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Pavan+A%22">Pavan A</searchLink>; Department of Medical Oncology, AULSS 3 Serenissima, Ospedale dell'Angelo, Venezia, Italy.<br /><searchLink fieldCode="AU" term="%22Roca+E%22">Roca E</searchLink>; Thoracic Oncology - Lung Unit, Pederzoli Hospital, Peschiera del Garda, Verona, Italy.<br /><searchLink fieldCode="AU" term="%22Minuti+G%22">Minuti G</searchLink>; Clinical Trials Unit - Phase 1 and Precision Medicine, IRCCS National Cancer Institute Regina Elena, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22D'Aniello+C%22">D'Aniello C</searchLink>; Unit of Oncology, A.O. dei Colli P.O. Monaldi, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Giusti+R%22">Giusti R</searchLink>; A.O.U. Sant'Andrea, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Mariotti+S%22">Mariotti S</searchLink>; Policlinico Tor Vergata, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Romano+FJ%22">Romano FJ</searchLink>; A.O.R.N. Cardarelli, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Polo+V%22">Polo V</searchLink>; Oncology Unit, AULSS 2 Marca Trevigiana, Ca' Foncello Hospital, Treviso, Italy.<br /><searchLink fieldCode="AU" term="%22Belluomini+L%22">Belluomini L</searchLink>; Section of Oncology, Department of Engineering for Innovation Medicine (DIMI), University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy.<br /><searchLink fieldCode="AU" term="%22Baldini+E%22">Baldini E</searchLink>; Ospedale San Luca, Lucca, Italy.<br /><searchLink fieldCode="AU" term="%22Mazzoni+F%22">Mazzoni F</searchLink>; Oncology Department, Careggi University Hospital, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Bettini+AC%22">Bettini AC</searchLink>; ASST Papa Giovanni XXIII, Bergamo, Italy.<br /><searchLink fieldCode="AU" term="%22Gristina+V%22">Gristina V</searchLink>; Department of Precision Medicine in Medical, Surgical and Critical Care, AOUP Paolo Giaccone University Hospital, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Russo+A%22">Russo A</searchLink>; A.O. Papardo, Messina, Italy.<br /><searchLink fieldCode="AU" term="%22Grossi+F%22">Grossi F</searchLink>; Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy.; Medical Oncology Division, ASST Sette Laghi, Varese, Italy.<br /><searchLink fieldCode="AU" term="%22Ogliari+FR%22">Ogliari FR</searchLink>; Dept. Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.; Università Vita-Salute San Raffaele, Pesaro (PU), Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Gelsomino+F%22">Gelsomino F</searchLink>; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Chiari+R%22">Chiari R</searchLink>; Ospedale San Salvatore - Muraglia, Pesaro (PU), Italy.<br /><searchLink fieldCode="AU" term="%22Bria+E%22">Bria E</searchLink>; Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Fioroni+I%22">Fioroni I</searchLink>; Policlinico Universitario Campus Bio-Medico, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Cortinovis+D%22">Cortinovis D</searchLink>; SC Medical Oncology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; Department of Medicine, University of Milano-Bicocca, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Pizzutilo+EG%22">Pizzutilo EG</searchLink>; ASST GOM Niguarda, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Zanetti+A%22">Zanetti A</searchLink>; AstraZeneca Italy, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Pasqualetti+G%22">Pasqualetti G</searchLink>; AstraZeneca Italy, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Roncari+B%22">Roncari B</searchLink>; IQVIA Solutions Italy SRL, Modena, Italy.<br /><searchLink fieldCode="AU" term="%22Simoni+L%22">Simoni L</searchLink>; IQVIA Solutions Italy SRL, Modena, Italy.<br /><searchLink fieldCode="AU" term="%22Catino+A%22">Catino A</searchLink>; Thoracic Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ELBA+Study+Group%22">ELBA Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Feb 16; Vol. 16, pp. 1724019. <i>Date of Electronic Publication: </i>2026 Feb 16 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41777656
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2026.1724019
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1724019
    Titles:
      – TitleFull: Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pasello G
      – PersonEntity:
          Name:
            NameFull: Proto C
      – PersonEntity:
          Name:
            NameFull: Genova C
      – PersonEntity:
          Name:
            NameFull: Pavan A
      – PersonEntity:
          Name:
            NameFull: Roca E
      – PersonEntity:
          Name:
            NameFull: Minuti G
      – PersonEntity:
          Name:
            NameFull: D'Aniello C
      – PersonEntity:
          Name:
            NameFull: Giusti R
      – PersonEntity:
          Name:
            NameFull: Mariotti S
      – PersonEntity:
          Name:
            NameFull: Romano FJ
      – PersonEntity:
          Name:
            NameFull: Polo V
      – PersonEntity:
          Name:
            NameFull: Belluomini L
      – PersonEntity:
          Name:
            NameFull: Baldini E
      – PersonEntity:
          Name:
            NameFull: Mazzoni F
      – PersonEntity:
          Name:
            NameFull: Bettini AC
      – PersonEntity:
          Name:
            NameFull: Gristina V
      – PersonEntity:
          Name:
            NameFull: Russo A
      – PersonEntity:
          Name:
            NameFull: Grossi F
      – PersonEntity:
          Name:
            NameFull: Ogliari FR
      – PersonEntity:
          Name:
            NameFull: Gelsomino F
      – PersonEntity:
          Name:
            NameFull: Chiari R
      – PersonEntity:
          Name:
            NameFull: Bria E
      – PersonEntity:
          Name:
            NameFull: Fioroni I
      – PersonEntity:
          Name:
            NameFull: Cortinovis D
      – PersonEntity:
          Name:
            NameFull: Pizzutilo EG
      – PersonEntity:
          Name:
            NameFull: Zanetti A
      – PersonEntity:
          Name:
            NameFull: Pasqualetti G
      – PersonEntity:
          Name:
            NameFull: Roncari B
      – PersonEntity:
          Name:
            NameFull: Simoni L
      – PersonEntity:
          Name:
            NameFull: Catino A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 02
              Text: 2026 Feb 16
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1